Yuan Yu
Research Subjects
Research Interests
Yuan Yu has a total of 19 co-authors. Here are the top co-authors by number of shared publications:
- Peng Kong
Department of Biochemistry and Molecular Biology, College of Basic Medicine, Key Laboratory of Medical Biotechnology of Hebei Province, Key Laboratory of Neural and Vascular Biology of Ministry of Education, Hebei Medical University, Shijiazhuang, P. R. China
2 shared publications Chuanfeng Zhang
Department of Biochemistry and Molecular Biology, Shandong Medical and Pharmaceutical University, Yantai, P.R. China
1 shared publication- Chuanfeng Zhang
Department of Biochemistry and Molecular Biology Binzhou Medical University Yantai ShanDong P.R. China
1 shared publication Chun‐Dong Li
Xilin Gol Institute of Bioengineering Xilin Gol Food Testing and Risk Assessment Center Xilingol Vocational College Xilinhot China
1 shared publicationGuangbin Sun
Department of Biochemistry and Molecular Biology Binzhou Medical University Yantai China
1 shared publication- Guangbin Sun
Department of Biochemistry and Molecular Biology, Binzhou Medical University, YanTai, ShanDong 264003, PR China
1 shared publication
Latest Publications
- Open Access
- 20 April 2026
- Published by Springer Nature in Biology Direct
- Vol. 21 (1)
CircAFF4 inhibits lung cancer progression via destabilizing GPX4 and triggering ferroptosis
Background: Lung cancer has been the most common diagnosed cancer and the leading cause of cancer-related death. Growing evidence has demonstrated that circular RNAs (circRNAs) are closely associated with the occurrence and progression of tumors. Ferroptosis is an iron-dependent form of cell death triggered by the accumulation of lipid peroxides, and it has been considered as a potential target for cancer therapy. However, the specific mechanism by which circRNAs modulate ferroptosis in lung cancer remains largely unknown. Methods: Through retrieval from The Cancer Genome Atlas (TCGA) database, the differential expression of AFF4 mRNA in lung cancer was identified. Further screening and validation revealed that circAFF4, a circular RNA derived from AFF4 host gene, also exhibited a similar trend in lung cancer. Subsequently, quantitative reverse transcription-PCR (qRT-PCR) and fluorescent in situ hybridization (FISH) were used to detect its expression pattern and distribution. Functional studies were conducted both in vitro and in vivo to determine the biological functions of circAFF4. Furthermore, the interaction between circAFF4 and ubiquitin-specific peptidase 10 (USP10) as well as the relationship between USP10 and Glutathione peroxidase 4 (GPX4), were investigated by biotin-labeled RNA pull-down, mass spectrometry, RNA immunoprecipitation (RIP), FISH and co-immunoprecipitation (Co-IP) assays. Results: Here we demonstrated that circAFF4 was significantly downregulated in lung cancer tissues and lung cancer cells. In vitro and in vivo experiments suggested that circAFF4 inhibited the proliferation of lung cancer cells and promoted ferroptosis. Mechanistically, circAFF4 bound to the deubiquitinating enzyme USP10, which in turn suppressed USP10-mediated deubiquitination of GPX4, and enhanced the ubiquitin-dependent proteasome degradation of GPX4, thereby facilitating ferroptosis in lung cancer cells. Conclusions: Our findings reveal a novel mechanism by which circAFF4 interacts with USP10, impairing USP10-mediated stabilization of GPX4, promoting ferroptosis in lung cancer cells, and ultimately suppressing lung cancer progression. The circAFF4/USP10/GPX4 axis provides a new direction and may be a potential target for lung cancer treatment.
- 20 April 2026
- Published by Springer Nature in Biology Direct
- Vol. 21 (1)
Open AccessCircAFF4 inhibits lung cancer progression via destabilizing GPX4 and triggering ferroptosis
Background: Lung cancer has been the most common diagnosed cancer and the leading cause of cancer-related death. Growing evidence has demonstrated that circular RNAs (circRNAs) are closely associated with the occurrence and progression of tumors. Ferroptosis is an iron-dependent form of cell death triggered by the accumulation of lipid peroxides, and it has been considered as a potential target for cancer therapy. However, the specific mechanism by which circRNAs modulate ferroptosis in lung cancer remains largely unknown. Methods: Through retrieval from The Cancer Genome Atlas (TCGA) database, the differential expression of AFF4 mRNA in lung cancer was identified. Further screening and validation revealed that circAFF4, a circular RNA derived from AFF4 host gene, also exhibited a similar trend in lung cancer. Subsequently, quantitative reverse transcription-PCR (qRT-PCR) and fluorescent in situ hybridization (FISH) were used to detect its expression pattern and distribution. Functional studies were conducted both in vitro and in vivo to determine the biological functions of circAFF4. Furthermore, the interaction between circAFF4 and ubiquitin-specific peptidase 10 (USP10) as well as the relationship between USP10 and Glutathione peroxidase 4 (GPX4), were investigated by biotin-labeled RNA pull-down, mass spectrometry, RNA immunoprecipitation (RIP), FISH and co-immunoprecipitation (Co-IP) assays. Results: Here we demonstrated that circAFF4 was significantly downregulated in lung cancer tissues and lung cancer cells. In vitro and in vivo experiments suggested that circAFF4 inhibited the proliferation of lung cancer cells and promoted ferroptosis. Mechanistically, circAFF4 bound to the deubiquitinating enzyme USP10, which in turn suppressed USP10-mediated deubiquitination of GPX4, and enhanced the ubiquitin-dependent proteasome degradation of GPX4, thereby facilitating ferroptosis in lung cancer cells. Conclusions: Our findings reveal a novel mechanism by which circAFF4 interacts with USP10, impairing USP10-mediated stabilization of GPX4, promoting ferroptosis in lung cancer cells, and ultimately suppressing lung cancer progression. The circAFF4/USP10/GPX4 axis provides a new direction and may be a potential target for lung cancer treatment.
- 21 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (4) , e70405
Circ‐Sirt6 promotes the stability and expression of m 6 A modified Sirt6 mRNA by recruiting IGF2BP2
Coronary artery disease (CAD) is the leading cause of death worldwide. Even though numerous circRNAs have been linked to the formation and progression of CAD, more circular RNA regulators still need to be uncovered in order to enhance the knowledge of the CAD regulatory networks. Microarray analysis was employed to identify aberrantly expressed circRNAs in vascular pathology, and the level of circ‐Sirt6 in abnormally proliferated vascular smooth muscle cells (VSMCs) was detected by qRT‐PCR. The effects of circ‐Sirt6, IGF2BP2, and Sirt6 on the proliferation and migration of VSMCs were examined by EdU incorporation assay and migration assays. The interaction between circ‐Sirt6, IGF2BP2, and Sirt6 was verified by RNA pull‐down assay, RIP, FISH, and immunofluorescent staining. Dot blot assay and m 6 A‐methylated RNA immunoprecipitation‐qPCR were performed to confirm that circ‐Sirt6 promoted m 6 A modification and stabilization of Sirt6 mRNA. According to our research, circ‐Sirt6 expression was markedly downregulated in VSMCs treated with PDGF‐BB and carotid artery balloon injury. The in vitro and in vivo proliferation and migration of VSMCs were inhibited by overexpression of circ‐Sirt6. Mechanistically, circ‐Sirt6 specifically binds to IGF2BP2 and promotes the stability and expression of Sirt6 mRNA by enhancing its m 6 A modification. Our findings highlight the importance of circ‐Sirt6‐mediated m 6 A in VSMC phenotype switching. Circ‐Sirt6 may be a novel biological target for CAD.
- 21 February 2025
- Published by Wiley in The FASEB Journal
- Vol. 39 (4) , e70405
Circ‐Sirt6 promotes the stability and expression of m 6 A modified Sirt6 mRNA by recruiting IGF2BP2
Coronary artery disease (CAD) is the leading cause of death worldwide. Even though numerous circRNAs have been linked to the formation and progression of CAD, more circular RNA regulators still need to be uncovered in order to enhance the knowledge of the CAD regulatory networks. Microarray analysis was employed to identify aberrantly expressed circRNAs in vascular pathology, and the level of circ‐Sirt6 in abnormally proliferated vascular smooth muscle cells (VSMCs) was detected by qRT‐PCR. The effects of circ‐Sirt6, IGF2BP2, and Sirt6 on the proliferation and migration of VSMCs were examined by EdU incorporation assay and migration assays. The interaction between circ‐Sirt6, IGF2BP2, and Sirt6 was verified by RNA pull‐down assay, RIP, FISH, and immunofluorescent staining. Dot blot assay and m 6 A‐methylated RNA immunoprecipitation‐qPCR were performed to confirm that circ‐Sirt6 promoted m 6 A modification and stabilization of Sirt6 mRNA. According to our research, circ‐Sirt6 expression was markedly downregulated in VSMCs treated with PDGF‐BB and carotid artery balloon injury. The in vitro and in vivo proliferation and migration of VSMCs were inhibited by overexpression of circ‐Sirt6. Mechanistically, circ‐Sirt6 specifically binds to IGF2BP2 and promotes the stability and expression of Sirt6 mRNA by enhancing its m 6 A modification. Our findings highlight the importance of circ‐Sirt6‐mediated m 6 A in VSMC phenotype switching. Circ‐Sirt6 may be a novel biological target for CAD.
- 6 January 2022
- Published by Wiley in Cell Biology International
- Vol. 46 (4) , 628-636
Circ‐Sirt1 inhibits vascular smooth muscle cells proliferation via the c‐Myc/cyclin B1 axis
Vascular smooth muscle cells (VSMCs) are an important cellular component of the vascular wall. Restenosis is mainly due to VSMC excessive proliferation. However, little is known about the role of circRNAs in VSMC proliferation and phenotypic switching. Herein, using fluorescence in situ hybridization assay and quantitative real‐time polymerase chain reaction, we found that circ‐Sirt1 was markedly downregulated in neointimal formation after injury and in VSMCs treated with platelet‐derived growth factor BB (PDGF‐BB). Bromodeoxyuridine and MTT assays confirmed the inhibitory role of circ‐Sirt1 on cell proliferation. Mechanistically, circ‐Sirt1 was mainly expressed in the cytoplasm of VSMCs. Through RNA immunoprecipitation and RNA pull‐down assays, we found that circ‐Sirt1 bound with c‐Myc, which protein associated with proliferation of VSMCs. Chromatin immunoprecipitation assay also provided evidence that the overexpression of circ‐Sirt1 almost ceased PDGF‐BB‐induced binding of c‐Myc to the promoter of cyclin B1 in VSMCs. These results indicated that circ‐Sirt1 had an inhibitory effect on c‐Myc activity, providing a mechanism for suppressing PDGF‐BB‐induced VSMC proliferation by direct interactions with c‐Myc and its sequestration in the cytoplasm. Overall, our study demonstrated that a previously unrecognized circ‐Sirt1/c‐Myc/cyclin B1 axis in VSMCs mediates neointimal formation following injury.
- 6 January 2022
- Published by Wiley in Cell Biology International
- Vol. 46 (4) , 628-636
Circ‐Sirt1 inhibits vascular smooth muscle cells proliferation via the c‐Myc/cyclin B1 axis
Vascular smooth muscle cells (VSMCs) are an important cellular component of the vascular wall. Restenosis is mainly due to VSMC excessive proliferation. However, little is known about the role of circRNAs in VSMC proliferation and phenotypic switching. Herein, using fluorescence in situ hybridization assay and quantitative real‐time polymerase chain reaction, we found that circ‐Sirt1 was markedly downregulated in neointimal formation after injury and in VSMCs treated with platelet‐derived growth factor BB (PDGF‐BB). Bromodeoxyuridine and MTT assays confirmed the inhibitory role of circ‐Sirt1 on cell proliferation. Mechanistically, circ‐Sirt1 was mainly expressed in the cytoplasm of VSMCs. Through RNA immunoprecipitation and RNA pull‐down assays, we found that circ‐Sirt1 bound with c‐Myc, which protein associated with proliferation of VSMCs. Chromatin immunoprecipitation assay also provided evidence that the overexpression of circ‐Sirt1 almost ceased PDGF‐BB‐induced binding of c‐Myc to the promoter of cyclin B1 in VSMCs. These results indicated that circ‐Sirt1 had an inhibitory effect on c‐Myc activity, providing a mechanism for suppressing PDGF‐BB‐induced VSMC proliferation by direct interactions with c‐Myc and its sequestration in the cytoplasm. Overall, our study demonstrated that a previously unrecognized circ‐Sirt1/c‐Myc/cyclin B1 axis in VSMCs mediates neointimal formation following injury.
- Open Access
- 19 October 2020
- Published by Wiley in Food Science & Nutrition
- Vol. 8 (12) , 6467-6476
Simultaneous detection of ovine and caprine DNA in meat and dairy products using triplex TaqMan real‐time PCR
In this study, we report a new approach for the detection of ovine and caprine DNA in meat and dairy products using real‐time PCR protocol. Our new approach is based on the use of endogenous control and species‐specific TaqMan fluorescence probes. With this methodology, we specifically detected ovine and caprine DNA in meat and dairy products, with limits of detection of 0.001 ng and 0.01 ng for fresh and processed ovine meats, respectively, and 0.00025 ng, 0.005 ng, and 0.01 ng for caprine meat, milk, and cheese, respectively. Artificial meat and milk mixtures from sheep and goat were used to validate the protocol. Our results support that TaqMan real‐time PCR with endogenous control is an efficient and accurate method to detect DNA from sheep and goat in meat and dairy products.
- 19 October 2020
- Published by Wiley in Food Science & Nutrition
- Vol. 8 (12) , 6467-6476
Open AccessSimultaneous detection of ovine and caprine DNA in meat and dairy products using triplex TaqMan real‐time PCR
In this study, we report a new approach for the detection of ovine and caprine DNA in meat and dairy products using real‐time PCR protocol. Our new approach is based on the use of endogenous control and species‐specific TaqMan fluorescence probes. With this methodology, we specifically detected ovine and caprine DNA in meat and dairy products, with limits of detection of 0.001 ng and 0.01 ng for fresh and processed ovine meats, respectively, and 0.00025 ng, 0.005 ng, and 0.01 ng for caprine meat, milk, and cheese, respectively. Artificial meat and milk mixtures from sheep and goat were used to validate the protocol. Our results support that TaqMan real‐time PCR with endogenous control is an efficient and accurate method to detect DNA from sheep and goat in meat and dairy products.